Diamyd Medical AB (OMX:DIAMB), based in Stockholm, Sweden, announced that it has agreed to acquire all of the outstanding shares in Nurel, which is based in the Pittsburgh Life Sciences Greenhouse in Hazelwood.
Diamyd Medical AB (OMX:DIAMB), based in Stockholm, Sweden, announced that it has agreed to acquire all of the outstanding shares in Nurel, which is based in the Pittsburgh Life Sciences Greenhouse in Hazelwood.